Newsroom

Industry News

21 Feb

Abeona Therapeutics Announces Upcoming Conference Participation

NEW YORK and CLEVELAND, Feb. 21, 2018 (GLOBE NEWSWIRE) –– Abeona Therapeutics Inc. (ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the Company’s senior management team will participate in the following investor and industry conferences. RBC Capital...

Read more

20 Feb

Ascent Solar’s Monolithically Integrated Thin-Film Solar Selected for Further Testing for Deep Space Exploration by the German Aerospace Center

THORNTON, CO, Feb. 20, 2018 (GLOBE NEWSWIRE) — Ascent Solar Technologies, Inc. (ASTI), a developer and manufacturer of state-of-the-art, lightweight and flexible thin-film photovoltaic (PV) solutions, announces that the company has been selected by the German Aerospace Center (Deutsches Zentrum für Luft- und Raumfahrt; DLR) for further testing to...

Read more

20 Feb

Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit

ANN ARBOR, Mich., Feb. 20, 2018 (GLOBE NEWSWIRE) — Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (ZOM.V) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced its participation in the Bank of America Merrill Lynch Animal Health Summit on Monday, February 26, 2018, in New York, NY. Chief Financial Officer Shameze...

Read more

20 Feb

Youngevity Completes Acquisition of Nature Direct

Australia Based Distributors of Essential-Oil Based Cleaning Products SAN DIEGO, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) — Youngevity International, Inc. (YGYI), a leading omni-direct lifestyle company, today announced the acquisition of Nature Direct, a manufacturer and distributor of essential-oil based nontoxic cleaning and care products for personal, home and professional use....

Read more

16 Feb

Intellipharmaceutics Announces Fiscal Year 2017 Results

TORONTO, ON / ACCESSWIRE / February 16, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the year...

Read more

14 Feb

Intellipharmaceutics Sets Earnings Release Date for Year End 2017 Results

TORONTO, ON / ACCESSWIRE / February 13, 2018 / Intellipharmaceutics International Inc. (IPCI) (IPCI) (”Intellipharmaceutics” or the ”Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- and targeted-release oral solid dosage drugs, today announced that the Company intends to release its fiscal year...

Read more

14 Feb

Myomo and GRE to Conduct Screening Days in Ohio and Detroit

CAMBRIDGE, Mass. & CHARDON, Ohio–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and Geauga Rehabilitation Engineering (GRE) have announced a series of free screening days to be held at the offices of GRE and its local partners near Cleveland, Detroit,...

Read more

14 Feb

Youngevity Announces Registration Statement on Form S-1 Has Been Declared Effective

SAN DIEGO, CA, Feb. 14, 2018 (GLOBE NEWSWIRE) — Youngevity International, Inc.  (YGYI), a leading omni-direct lifestyle company, today announced that the Securities and Exchange Commission has declared effective the Company’s registration statement on Form S-1, as amended (File No. 333-221847), relating to the proposed offer and sale of up to...

Read more

13 Feb

Trovagene Announces Activation of Two Additional Clinical Trial Sites to Conduct its Phase 1b/2 Study of PCM-075 in Patients with AML

Yale Cancer Center and Kansas University Cancer Center now actively screening and enrolling patients in Phase 1b/2 Study of PCM-075 in Acute Myeloid Leukemia (AML) SAN DIEGO, Feb. 13, 2018 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, developing targeted oncology therapeutics, today announced the addition of two leading institutions,...

Read more

Page 1 of 28112345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address